Gallbladder disease in the general population: Association with cardiovascular morbidity and therapy

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue 5, 2007, Pages 524-531

  González Pérez, Antonio ^a,b   García Rodríguez, Luis A ^a  

^a Department of Pharmacoepidemiology   (Spain)

^b NONE   (Spain)

Author keywords

Antihypertensive agents; Gallbladder (GB) disease; Ischaemic heart disease (IHD); Observational studies; Thiazide diuretics

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; ORAL CONTRACEPTIVE AGENT; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CHOLECYSTECTOMY; CHOLECYSTITIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; DRUG MEGADOSE; DRUG SAFETY; FEMALE; GALLBLADDER DISEASE; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OBSERVATIONAL STUDY; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING;

ADULT; AGE FACTORS; AGE OF ONSET; AGED; ALCOHOL DRINKING; CASE-CONTROL STUDIES; CHOLECYSTITIS; COMORBIDITY; DIURETICS; GREAT BRITAIN; HUMANS; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OBESITY; POPULATION SURVEILLANCE; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SMOKING; THIAZIDES;

EID: 34249749390     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1346     Document Type: Article

References (27)

1. Maclure KM, Hayes KC, Colditz GA, et al. Weight, diet, and the risk of symptomatic gallstones in middle-aged women. N Engl J Med 1989; 321: 563-569.
2. Mendez-Sanchez N, Chavez-Tapia NC, Motola-Kuba D, et al. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol. 2005; 11: 1653-1657.
3. Pagliarulo M, Fornari F, Fraquelli M, et al. Gallstone disease and related risk factors in a large cohort of diabetic patients. Dig Liver Dis 2004; 36: 130-134.
4. Bateson MC. Fortnightly review: gallbladder disease. BMJ 1999; 318: 1745-1748.
5. Bortnichak EA, Freeman DH, Ostfeld AM, et al. The association between cholesterol cholelithiasis and coronary heart disease in Framingham, Massachusetts. Am J Epidemiol 1985; 121: 19-30.
6. Petitti DB, Wingerd J, Pellegrin F, et al. Risk of vascular disease in women. Smoking, oral contraceptives, noncontraceptive estrogens, and other factors. JAMA 1979; 242: 1150-1154.
7. Friedman GD. The relationship between coronary heart disease and gallbladder disease: A critical review. Ann Intern Med 1968; 68: 222-235.
8. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.
9. Leitzmann MF, Tsai CJ, Stampfer MJ, et al. Thiazide diuretics and the risk of gallbladder disease requiring surgery in women. Arch Intern Med 2005; 165: 567-573.
10. Angelin B. Effect of thiazide treatment on biliary lipid composition in healthy volunteers. Eur J Clin Pharmacol 1989; 37: 95-96.
11. Logan GM, Duane WC. Lovastatin added to ursodeoxycholic acid further reduces biliary cholesterol saturation. Gastroenterology 1990; 98: 1572-1576.
12. Sackmann M, Koelbl R, Pauletzki J, et al. Simvastatin added to ursodeoxycholic acid does not enhance disappearance of gallstone fragments after shock wave therapy. Z Gastroenterol 1995; 33: 585-589.
13. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991; 302: 766-768.
14. Mendez-Sanchez N, Bahena-Aponte J, Chavez-Tapia NC, et al. Strong association between gallstones and cardiovascular disease. Am J Gastroenterol 2005; 100: 827-830.
15. Rosenberg L, Shapiro S, Slone D, et al. Thiazides and acute cholecystitis. N Engl J Med 1980; 303: 546-548.
16. Van der Linden W, Ritter B, Edlund G. Acute cholecystitis and thiazides. BMJ (Clin Res Ed) 1984; 289: 654-655.
17. Porter JB, Jick H, Dinan BJ. Acute cholecystitis and thiazides. N Engl J Med 1981; 304: 954-955.
18. O'Fallon WM, Labarthe DR, Kurland LT. Rauwolfia derivatives and breast cancer: a case/control study in Olmsted County, Minnesota. Lancet 1975; 2: 292-296.
19. Stampfer MJ, Maclure KM, Colditz GA, et al. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr 1992; 55: 652-658.
20. Maurer KR, Everhart JE, Knowler WC, et al. Risk factors for gallstone disease in the Hispanic populations of the United States. Am J Epidemiol 1990; 131: 836-844.
21. Grodstein F, Colditz GA, Hunter DJ, et al. A prospective study of symptomatic gallstones in women: relation with oral contraceptives and other risk factors. Obstet Gynaecol 1994; 82: 207-214.
22. Pastides H, Tzonou A, Trichopoulos D, et al. A case control study of the relationship between smoking, diet and gallbladder disease. Arch Intern Med 1990; 150: 1409-1412.
23. Leitzmann MF, Tsai CJ, Stampfer MJ, et al. Alcohol consumption in relation to risk of cholecystectomy in women. Am J Clin Nutr 2003; 78: 339-347.
24. Cirillo DJ, Wallace RB, Rodabough RJ, et al. Effect of estrogen therapy on gallbladder disease. JAMA 2005; 293: 330-339.
25. Donovan JM. Physical and metabolic factors in gallstone pathogenesis. Gastroenterol Clin North Am 1999; 28: 75-97.
26. Thijs C, Knipschild P. Oral contraceptives and the risk of gallbladder disease: a meta-analysis. Am J Public Health 1993; 83(8): 1113-1120.
27. Vessey M, Painter R. Oral contraceptive use and benign gallbladder disease; revisited. Contraception 1994; 50(2): 167-173.